POLAT-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for POLAT-001, covering 2020-11-16 to 2020-11-16. Get the full timeline:
Most recent: Clinical Trial Update: POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle Glaucoma [Phase 2]